Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2017Yazar
Erfan, GamzePuig, Susana
Carrera, Cristina
Arance, Ana
Gaba, Lydia
Victoria, Ivan
Malvehy, Josep
Üst veri
Tüm öğe kaydını gösterÖzet
[No Abstract Available]